Endocrinology Search
Endocrinology Endocrinology
hypocalcemia
HYPOCALCEMIA
Hypocalcemia is the occurs when serum calcium concentration is below the lower limit of normal range.
Acute hypocalcemia has neuromuscular tetany as hallmark symptom. Patients have rapid decrease in serum calcium and present with symptomatic hypocalcemia.
It is an emergency condition and requires immediate attention. Ca (IV) should be administered until signs and symptoms abate or until serum Ca levels rise.
Chronic hypocalcemia has asymptomatic mild hypocalcemia. Treatment is necessary to avoid long term complications. Oral Ca may be administered.
Drug Information

Indication: Treatment & prevention of vit D deficiency. Adjunctive treatment for osteoporosis. Reduces risk of falling...

Indication: Ca dietary supplement.

Indication: Correction of combined vit D & Ca deficiency in the elderly. Adjunct to treatment of osteoporosis in patie...

Indication: Health supplement.

Indication: Prevention & treatment of Ca deficiency.

Calcium with Vitamin D Plus YSP
calcium carbonate + vitamin D

Indication: Dietary supplement.

Calcium with Vitamin D YSP
calcium + vitamin D3

Indication: Prevention of Ca deficiency.

Cebion Vitamin C + Calcium Effervescent Tablet
ascorbic acid + calcium carbonate

Indication: Health supplement.

Indication: Ca deficiency & hypocalcaemia.

Proscal
calcium + magnesium + phosphorus + vitamin D3

Indication: Nutritional supplement as a source of Ca for healthy bones.

1  /  3
1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Resistant starch supplementation does not improve glycaemic control in prediabetic adults
06 Oct 2018
Supplementation with resistant starch for 12 weeks decreases the inflammatory marker tumour necrosis factor [TNF]-α and heart rate but does not significantly improve glycaemic control and other cardiovascular disease risk factors in prediabetic adults, suggests a study.
Medroxyprogesterone acetate tied to minimal side effects, lower testosterone levels in transwomen
3 days ago
Use of the feminizing hormone therapy medroxyprogesterone acetate (MPA) results in minimal side effects, unchanged oestradiol levels and a decline in testosterone in a cohort of transwomen, a study has found.
Adulthood overweight exerts lifelong effect on breast, colorectal cancer survival
29 Sep 2019
The duration and degree of overweight in adulthood appear to have lasting influence on breast and colorectal cancer survival, a study has found.
Diabetes risk higher in postmenopausal women with breast cancer
22 Jul 2019
The risk of diabetes mellitus is higher among postmenopausal women who develop primary breast cancer, reports a new study.